• Merck gears up to file antiviral letermovir in the US, EU pharmatimes
    February 28, 2017
    Merck & Co said it is planning to submit regulatory applications for letermovir in the US and European Union sometime this year, on the back of late-stage data showing its promise in preventing a serious viral infection in patients undergoing a bone marro
PharmaSources Customer Service